semaglutide bmi reduction
Stop Losing Patients to Prescription Weight Loss
Among semaglutide, tirzepatide and orforglipron, tirzepatide delivers the greatest average BMI reduction, achieving about a 7.8% loss in phase-III studies, while the other agents still provide meaningful weight loss for diabetic patients. Clinicians who pair these agents with lifestyle coaching see better cardiovascular outcomes and lower long-term costs. In